Caris Life Sciences, Inc. (CAI)
30.51
+0.26
(+0.84%)
USD |
NASDAQ |
Oct 15, 10:02
Caris Life Sciences Total Long Term Debt (Quarterly) : 446.04M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 446.04M |
| March 31, 2026 | 425.12M |
| December 31, 2025 | 421.33M |
| September 30, 2025 | 420.29M |
| June 30, 2025 | 411.69M |
| Date | Value |
|---|---|
| March 31, 2025 | 413.80M |
| December 31, 2024 | 418.18M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| CareDx, Inc. | 13.20M |
| Natera, Inc. | 143.07M |
| Myriad Genetics, Inc. | 203.20M |
| BioRestorative Therapies, Inc. | 0.00 |
| Exagen, Inc. | 26.68M |